Feb.22 -- Foxhall Internists Internal Medicine Physician Lucy Mcbride discusses results of the latest study on the efficacy of the Pfizer-BioNTech vaccine, achieving herd immunity through vaccinations, and the questions that remain about reopening schools. She speaks on “Bloomberg Surveillance Early Edition.”
As featured on
Precautions will be necessary until enough people have been vaccinated against COVID to reach herd immunity, and transmission of the coronavirus has been further reduced.
Johnson & Johnson is expected to get an Emergency Use Authorization as early as this weekend for its vaccine candidate, which is likely to mean an extra 15,000 doses for Nebraska in the first week.